2026/03/31 by Nynke A. Jager, Helmy Hinkema, Joop D. Lefrandt +5 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Glycation End Products research #Skin Protection and Aging #Antioxidant Activity and Oxidative Stress
paper · doi:10.1177/1358863x261420325
openalex publication_date 2026/03/31 · openalex created_date 2026/04/01 · openalex updated_date 2026/05/21
BACKGROUND: Advanced glycation end products (AGEs) may promote arterial matrix remodeling via the receptor for AGEs (RAGE) signaling. Skin autofluorescence estimates tissue AGE burden. We examined whether skin autofluorescence relates to circulating matrix metalloproteinases (MMPs) and subclinical carotid atherosclerosis in asymptomatic adults. METHODS: In a cross-sectional cohort of 262 asymptomatic adults, skin autofluorescence was measured with the AGE Reader. Plasma concentrations of MMP-3, MMP-9, tissue inhibitor of metalloproteinases-1 (TIMP-1), high-sensitivity C-reactive protein (hsCRP), and soluble RAGE (sRAGE) were measured by enzyme-linked immunosorbent assay (ELISA). Carotid intima-media thickness (IMT) and plaque burden were quantified by ultrasound. Associations between skin autofluorescence and biomarkers were tested using multivariable linear regression with prespecified covariates; biomarker coefficients were scaled per 10 ng/mL (hsCRP per 1 mg/L). RESULTS: = 0.41). Plaque-positive participants had higher skin autofluorescence, MMP-9, and hsCRP than those without plaques; MMP-9 and hsCRP were also higher in the high- versus intermediate-plaque group, whereas MMP-3 and TIMP-1 did not differ. CONCLUSIONS: In asymptomatic adults, higher skin autofluorescence is independently associated with circulating MMP-3, MMP-9, and TIMP-1, and with early carotid atherosclerosis markers. Findings support a link between tissue glycation and arterial matrix remodeling and suggest that skin autofluorescence plus MMP-9 may offer a practical, noninvasive approach for early vascular risk stratification.